FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I-a1) or a pharmaceutically acceptable salt thereof. In formula (I-a1), Z represents a group of formulae (iv) (iv); L3 is C1-C6alkylene; R3b is hydrogen; R3a is C1-C6alkyl; -OR3b is in the beta position and R3a is in the alpha position; each of R2, R11a and R11b is hydrogen; R6a is hydrogen; Y is -O-; RZ5 is hydrogen; each of RZ6 is independently hydrogen or C1-C6alkyl. Invention also relates to a pharmaceutical composition and to a method for preventing, treating, improving a condition or controlling a disease or pathological condition mediated by the NMDA receptor modulator. (I-a1).
EFFECT: technical result: novel compounds of formula (I-a1), which are potential modulators of NMDA receptors, are obtained.
7 cl, 37 ex
Title | Year | Author | Number |
---|---|---|---|
NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2012 |
|
RU2808165C2 |
NEUROACTIVE STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2808166C2 |
NEUROACTIVE STEROIDS AND METHODS FOR USE THEREOF | 2014 |
|
RU2684103C2 |
COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2810331C2 |
OXYSTEROLS AND THEIR APPLICATION METHODS | 2017 |
|
RU2754130C2 |
OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2744267C2 |
COMPOSITIONS AND METHODS OF THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2799448C2 |
NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
19-NOR NEUROACTIVE STEROIDS AND METHODS OF USING THEM | 2014 |
|
RU2700264C2 |
COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | 2015 |
|
RU2733756C2 |
Authors
Dates
2018-08-31—Published
2012-09-07—Filed